您的位置: 首页 > 农业专利 > 详情页

Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
专利权人:
UNIVERSITY OF MARYLAND; BALTIMORE
发明人:
Lai-Xi Wang,Wei Huang
申请号:
US15843160
公开号:
US10344063B2
申请日:
2017.12.15
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention provides for recombinant Endo-S mutants that exhibit reduced hydrolysis activity and increased transglycosylation activity for the synthesis of glycoproteins wherein a desired sialylated oxazoline or synthetic oligosaccharide oxazoline is added to a core fucosylated or nonfucosylated GlcNAc-protein acceptor. Such recombinant Endo-S mutants are useful for efficient glycosylation remodeling of IgG1-Fc domain to provide different antibody glycoforms carrying structurally well-defined Fc N-glycans.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充